Tirzepatide, a dual receptor agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) helps in weight loss, but its effects on cardiovascular outcomes are unclear
Jumping to a higher dose too quickly is a common cause of intense gastrointestinal distress and may lead to stopping the treatment altogether
Given the increasing interest in peptide drugs because of their low production costs, high potency, selectivity, and biological stability, our research underscores the potential of finding a peptide analgesic that precisely targets and modulates TRPV1 without causing adverse effects
Regulation of mitochondrial and cytosolic malic enzymes from cultured rat brain astrocytes
Functional foods and bioactive compounds: A comprehensive review on their role in mitigating drug-induced liver injury
Lyophilized retatrutide can tolerate ambient temperature (up to 25C) for 2448 hours without significant degradation, but extended exposure causes 1525% monthly potency loss